Representative before the EPO

Company dna page white and farrer
no operation time available
2 offices
active in Legal Services

Clare Jean Stephens has worked on the following 26 EPO patent applications which have been published in the last five years:

EP12787022

NUCLEIC ACID PRODUCTION AND SEQUENCE ANALYSIS

IPC classification:
C12Q 1/68
Applicant:
Vilnius University (Vilniaus universitetas)
Agent:
Clare Jean Stephens, Page White & Farrer
Agent:
Jurga Petniunaite, AAA Law Patent & Trademark Attorney (AAA Patendibüroo OÜ)
Status:
PATENT GRANTED
EP12798723

USES OF IMMUNOCONJUGATES TARGETING CD138

IPC classification:
A61K 47/48, A61P 35/00
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP14170861

Agents targeting CD138 and uses thereof

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/30
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP12825119

MULTI-COPY STRATEGY FOR HIGH-TITER AND HIGH-PURITY PRODUCTION OF MULTI-SUBUNIT PROTEINS SUCH AS A ANTIBODIES IN TRANSFORMED MICROBES SUCH AS PICHIA PASTORIS

IPC classification:
C07K 16/00, C12N 1/19, C12N 1/38, C12N 15/12, C12N 15/63, C12P 21/00, C12P 21/08
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP12788717

USE OF ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES OR ANTIBODY FRAGMENTS TO TREAT OR PREVENT CHRONIC AND ACUTE FORMS OF DIARRHEA

IPC classification:
A61K 31/7088, A61K 38/16, A61K 39/00, A61K 39/395, A61K 45/06, A61K 48/00, A61P 1/12, C07K 16/26
Applicant:
University of Iowa Research Foundation
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP13784744

T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS

IPC classification:
A61K 35/12, A61P 35/00, C12N 5/0783, C12N 5/10
Applicant:
Trustees of Dartmouth College
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP13787331

ANTI-PCSK9 ANTIBODIES AND USE THEREOF

IPC classification:
A61K 39/395, A61P 3/00, C07K 16/18, C07K 16/42
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13784566

GENE EXPRESSION SIGNATURE FOR IL-6/STAT3 SIGNALING PATHWAY AND USE THEREOF

IPC classification:
C12N 15/11, C12Q 1/68, G01N 33/53
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13787935

ANTI-B7-H6 ANTIBODY, FUSION PROTEINS, AND METHODS OF USING THE SAME

IPC classification:
C07K 16/28
Applicant:
Trustees of Dartmouth College
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13806673

NOVEL VISTA-IG CONSTRUCTS AND THE USE OF VISTA-IG FOR TREATMENT OF AUTOIMMUNE, ALLERGIC AND INFLAMMATORY DISORDERS

IPC classification:
A61K 39/00, A61P 35/00, A61P 37/00, C07K 14/47, C07K 19/00
Applicant:
Trustees of Dartmouth College
Applicant:
King's College London
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP13834707

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

IPC classification:
A61K 39/395, A61K 48/00, A61P 35/00
Applicant:
Trustees of Dartmouth College
Applicant:
King's College London
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP14151373

Method for preparing a flame retardant modified acrylonitrile-based copolymer and a flame retardant fibrous material

IPC classification:
C08F 20/44, C08F 220/44, D01F 6/18, D01F 6/38, D01F 9/22
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15248004

IMPROVED MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA

IPC classification:
C12N 5/0797
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP15248003

IMPROVED MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA

IPC classification:
A01N 63/00, A01N 65/00, A61K 35/12, A61K 35/44, A61K 48/00, C12N 5/079, C12N 5/0793
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP13869692

HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF COLON AND PANCREAS CANCER

IPC classification:
C07K 16/18, G01N 33/574
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
GRANT OF PATENT INTENDED
EP15164137

DERIVATION OF EMBRYONIC STEM CELLS

IPC classification:
C12N 5/00, C12N 5/02, C12N 5/073, C12N 5/0735, C12N 5/075, C12N 15/82, C12N 15/873
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP14764393

TEMPERATURE SHIFT FOR HIGH YIELD EXPRESSION OF POLYPEPTIDES IN YEAST AND OTHER TRANSFORMED CELLS

IPC classification:
C12N 1/16, C12N 1/19, C12P 21/00
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP14763076

ANTIBODY PURIFICATION AND PURITY MONITORING

IPC classification:
C12N 1/19
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP16163265

DNA POLYMERASE MUTANTS HAVING INCREASED THERMOSTABILITY AND PROCESSIVITY

IPC classification:
C12N 9/12, C12P 19/34, C12Q 1/68
Applicant:
Thermo Fisher Scientific Baltics UAB
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP16177660

PRODUCTION OF NUCLEIC ACID

IPC classification:
C12N 9/12, C12N 15/10
Applicant:
Thermo Fisher Scientific Baltics UAB
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
Request for examination was made
EP15748635

IMPROVED PROCESS FOR THE SYNTHESIS OF SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES

IPC classification:
A23F 5/40, A61K 31/422, A23L 27/20
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15752472

ANTI-ACTH ANTIBODIES AND USE THEREOF

IPC classification:
A61K 39/00, C07K 16/00, C12P 21/08
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15716147

MODIFIED ANTIBODIES CONTAINING MODIFIED IGG2 DOMAINS WHICH ELICIT AGONIST OR ANTAGONISTIC PROPERTIES AND USE THEREOF

IPC classification:
C07K 16/28
Applicant:
Cancer Research Technology Ltd
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15796829

HIGH THROUGHPUT TELOMERIC CIRCLE ASSAY

IPC classification:
C12Q 1/68
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
EXAMINATION REQUESTED
EP15838895

COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF

IPC classification:
A61K 38/19, A61K 39/395, C07K 16/24, C12P 21/08
Applicant:
Boehringer Ingelheim International GmbH
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
Request for examination was made
EP15865129

IDENTIFICATION OF VSIG8 AS THE PUTATIVE VISTA RECEPTOR AND ITS USE THEREOF TO PRODUCE VISTA/VSIG8 MODULATORS

IPC classification:
A61K 38/16, A61K 39/395, C07K 16/46
Agent:
Clare Jean Stephens, Page White & Farrer
Status:
Request for examination was made

Please Sign in to use this feature